These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 19614557

  • 1. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.
    Plantinga TS, van der Velden WJ, Ferwerda B, van Spriel AB, Adema G, Feuth T, Donnelly JP, Brown GD, Kullberg BJ, Blijlevens NM, Netea MG.
    Clin Infect Dis; 2009 Sep 01; 49(5):724-32. PubMed ID: 19614557
    [Abstract] [Full Text] [Related]

  • 2. The incidence of acute graft-versus-host disease increases with Candida colonization depending the dectin-1 gene status.
    van der Velden WJ, Plantinga TS, Feuth T, Donnelly JP, Netea MG, Blijlevens NM.
    Clin Immunol; 2010 Aug 01; 136(2):302-6. PubMed ID: 20452827
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans.
    Saijo S, Fujikado N, Furuta T, Chung SH, Kotaki H, Seki K, Sudo K, Akira S, Adachi Y, Ohno N, Kinjo T, Nakamura K, Kawakami K, Iwakura Y.
    Nat Immunol; 2007 Jan 01; 8(1):39-46. PubMed ID: 17159982
    [Abstract] [Full Text] [Related]

  • 8. Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis.
    Jantunen E, Nihtinen A, Volin L, Juvonen E, Parkkali T, Ruutu T, Anttila VJ.
    Bone Marrow Transplant; 2004 Nov 01; 34(10):891-5. PubMed ID: 15517009
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.
    McCoy D, Depestel DD, Carver PL.
    Pharmacotherapy; 2009 Nov 01; 29(11):1306-25. PubMed ID: 19857148
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A new step toward individualized antifungal prevention in hematopoietic stem cell transplantation.
    Bochud PY, Calandra T.
    Clin Infect Dis; 2009 Sep 01; 49(5):733-5. PubMed ID: 19614558
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis.
    Chai LY, de Boer MG, van der Velden WJ, Plantinga TS, van Spriel AB, Jacobs C, Halkes CJ, Vonk AG, Blijlevens NM, van Dissel JT, Donnelly PJ, Kullberg BJ, Maertens J, Netea MG.
    J Infect Dis; 2011 Mar 01; 203(5):736-43. PubMed ID: 21242599
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients.
    Hamza NS, Ghannoum MA, Lazarus HM.
    Bone Marrow Transplant; 2004 Sep 01; 34(5):377-89. PubMed ID: 15247928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.